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Editorial
Wise choices: making physiotherapy care more valuable
Adrian C Traeger a, Ray N Moynihan b, Chris G Maher a
a School of Public Health, Sydney Medical School, University of Sydney; bCentre for Research in Evidence-Based Practice, Bond University, Gold Coast, Australia
There is a growing global awareness of the problem of low-
value healthcare. Low-value healthcare broadly refers to the use of
medical tests, diagnoses and treatments that provide patients with
little-to-no beneﬁt or cause harm.1 By providing unnecessary care
to one group of patients, we divert ﬁnite health resources away
from where they could be much better deployed. Elshaug et al
recently identiﬁed at least 150 low-value healthcare practices
currently listed on the Australian Medicare Beneﬁts Schedule.1
While much of the literature about low-value care relates directly
to medical tests and treatments, we believe that the problem is
highly relevant to physiotherapy. In this article, we focus on one of
the most common conditions seen by physiotherapists  low back
pain. Low back pain causes the highest burden of any health
condition worldwide and has considerable evidence to suggest
that its management is permeated by low-value care.
What is low-value healthcare?
Scott and Duckett deﬁne low-value care as:
use of an intervention where evidence suggests it confers no or very
little beneﬁt on patients, or risk of harm exceeds likely beneﬁt, or,
more broadly, the added costs of the intervention do not provide
proportional added beneﬁts.2
The concept of low-value care is related to a range of other
challenges, including overdiagnosis and overtreatment, which, put
simply, are situations where people receive a diagnosis or
treatment thatwill bring themmore harm than good.1 Collectively,
these problems are known as the health challenge of ‘Too Much
Medicine’3 and ‘Right Care’,4 which are the titles of current
campaigns being run by two of the world’s leading medical
journals: The BMJ and The Lancet. Table 1 lists a number of
related concepts, as deﬁned by Carter et al,5 and we have added
some illustrative examples that are relevant to physiotherapy
practice.6–10
Examples of low-value healthcare
There is growing evidence suggesting that low-value medical
care is prevalent in health problems commonly seen by
physiotherapists. In 2012 and 2013, Australian surgeons per-
formed 33 682 knee arthroscopies, despite high-quality evidence
from randomised trials that these procedures are not effective
compared to placebo for patients with degenerative meniscal
tears.11 Prescription of opioids for back pain is rising, despite their
poor efﬁcacy in patients with chronic low back pain and signiﬁcant
risk of harm.12 At the same time, prescriptions for alternative
analgesics with a better safety proﬁle are declining. There is also
increasing evidence that practitioners overuse imaging for patients
with non-speciﬁc low back pain, which, apart from being very
costly, exposes patients to the harms of ionising radiation,
diagnostic labelling, and unnecessary surgeries.8 These examples
are not simply the responsibility of doctors and their patients;
physiotherapists frequently inﬂuence decisions about imaging,
medication and surgery by the advice they provide to their patient
or by their referrals.
Indeed, like all areas of healthcare, physiotherapy also faces the
problem of unnecessary tests and treatments. As part of the
Australian ‘Choosing Wisely’ initiative, the Australian Physiother-
apy Association surveyed members in 2015 and developed a list of
six low-value physiotherapy practices, accompanied by evidence
that the test or treatment provided little beneﬁt or caused harm
(Box 1). Some well-known examples of low-value practices were
referral for x-rays without the use of a validated decision tool,
electrotherapy for low back pain, and ongoing manual therapy for
adhesive capsulitis of the shoulder. The Association promoted the
list to members and health consumers as areas of practice that
should be questioned.
In 2014, the American Physical Therapy Association surveyed
their 88 000 members and developed a list of ﬁve low-value
physiotherapy practices. That list included using: whirlpools for
wound management, deep or superﬁcial heat to promote long-
term improvements in musculoskeletal conditions, and continu-
ous passive motion machines for patients after total knee
replacement. Interestingly, there was no overlap between the
Australian and American Choosing Wisely lists for physiotherapy
care, which could reﬂect: international differences in scope of
practice, international differences in which low-value interven-
tions are used, a lack of consensus on the most important low-
value physiotherapy practices to address, or differences in the way
that lists are developed between countries.
Indeed, the process of identifying low-value practices is
controversial. Clinicians, for example, rarely consider an interven-
tion to have zero value for all patients. More commonly, a test or
treatment is effective for certain patients, but becomesmuchmore
widely used, includingwith those for whom it will bring little or no
beneﬁt. The most useful methods to identify low-value care are to
combine systematic literature searches with clinical expert panel
discussions.1 Developing a standardised framework for identifying
low-value services, and changing practice, are both important
ongoing areas for future research.
What is causing low-value care?
Evidence about important causes of low-value care is starting to
emerge. Drivers include technological, professional, commercial
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and cultural factors.3 Improvements in technology and increasing-
ly sensitive diagnostic tests are thought to drive overdiagnosis and
overdetection.3 For example, imaging for back,10 shoulder13 and
knee pain14 runs the risk of diagnosing and then subsequently
treating clinically insigniﬁcant ‘abnormalities’ that are highly
prevalent in asymptomatic people. Another important driver of
low-value care is expanding disease deﬁnitions. Lowering the
threshold at which a person is classiﬁed as ‘diseased’, or creating
new disease deﬁnitions, increases the likelihood of overdiagnosis
and overtreatment. A recent study revealed almost 75% of panel
members responsible for making changes to disease deﬁnitions or
diagnostic thresholds had multiple ﬁnancial ties to industries that
stand to directly beneﬁt from any expansion of the patient pool.15
There are also important personal, psychological and wider
cultural drivers of low-value healthcare. Many practitioners order
tests as a matter of habit. Others do so because they ﬁnd it difﬁcult
to do nothing, have fear of litigation if serious disease is missed, or
feel pressured by their patients.3 In a recent qualitative study by
Sears et al,16 around 50% of all practitioners cited concern about
upsetting their patient as a barrier to providing appropriate
imaging for back pain. In general, consumers of healthcare can ﬁnd
it difﬁcult to accept uncertainty. Fears and concerns about illness
also drive people to consultmore often.17 There is widespread faith
in medical technology and beliefs that more care is better care and
that early detection of disease is always best.18 As such, patients
tend to overestimate the beneﬁts and underestimate the harms of
many tests and treatments.19 ‘False feedback loops’, where
patients and practitioners wrongly ascribe improvements in a
mild condition to the treatment given, also fuel overtreatment.3
How can we make physiotherapy care more valuable?
Most commentators accept that the solution is not simply to
stop providing low-value care, but rather that high-value
healthcare requires the replacement of inappropriate care with
appropriate care. As Atul Gawande has argued, ‘unnecessary care
often crowds out necessary care, particularly when the necessary
care is less remunerative’.20 For example, exercise therapy appears
to be a safe and effective alternative to arthroscopic surgery for
people with knee pain and signs of a degenerative meniscal tear.10
The ﬁrst step towards making physiotherapy more valuable is
to identify low-value services and investigate the reasons why
practitioners choose them. The global ChoosingWisely campaigns,
which began in the United States in 2012, are now active in
12 countries.21 However, these campaigns are not without
problems. There are ongoing debates about the merits of the
ChoosingWisely recommendations as research evidence evolves –
some lists might recommend against interventions that research-
ers are actively researching. This could hinder attempts to
strengthen the evidence base for physiotherapy. There is also
little evidence that choices are getting any wiser. For example,
Choosing Wisely published a recommendation from the American
College of Physicians to not order imaging for patients with non-
speciﬁc low back pain, and yet lumbar imaging rates have not
changed since the launch of the US campaign.22 While it raises
international awareness about low-value care, simple passive
posting of lists is unlikely to be sufﬁcient to change practice.
Table 1
Deﬁnitions and examples of different types of low-value healthcare. Adapted from Carter et al.4
Term Deﬁnition Example
Overdiagnosis An (asymptomatic) person is diagnosed with a condition. That
diagnosis does not produce a net beneﬁt for that person.
A young adult being diagnosed with Scheuermann’s disease.
Overdetection A health-related ﬁnding is detected in an (asymptomatic) person,
probably by testing technology. That ﬁnding does not produce a net
beneﬁt for that person.
Incidental ﬁndings on lumbar imaging. Systematic review found
60% of asymptomatic 50-year olds have disc bulge on CT or MRI.9
False positive Classically: a test indicates that a condition is present, when in fact
it is not. In practice: there is often a ‘grey zone’ between normal and
abnormal tissue or function, and in this zone it is not always
possible to distinguish false positive results from overdiagnosis.
Red ﬂags to identify serious spinal pathology. A cohort study in
Australia found that 80% of 1172 patients with acute back pain had
at least one red ﬂag present, but <1% had serious spinal pathology.5
Overtreatment Provision of treatments that have evidence of no net beneﬁt or
that cause harm.
Use of ineffective therapies for low back pain. In 2000, a survey of all
Thai physiotherapists (n=559) reported that 61% advocated use of
treatments shown to have no net beneﬁt for patients with back pain,
such as ultrasound and mechanical traction.6
Overutilisation Establishment of standard practice in health services or systems
that do not provide net beneﬁt to patients or citizens.
Imaging for low back pain. 66 million lumbar radiographs were
performed in the United States in 2004,7 despite its discouragement
in clinical guidelines.
Expanded deﬁnitions
or disease mongering
Expansion of ofﬁcial disease or risk categories, or creating new
conditions, or promoting more frequent diagnosis of recognised
conditions, without net beneﬁt to patients or citizens.
Pharmaceutical companies promoting new variants of non-speciﬁc
low back pain, eg, ‘neuropathic back pain’ or ‘inﬂammatory back
pain’ that require treatment with a medicine the company markets.
Evidence is lacking on whether these new classiﬁcations lead to
improved outcomes.
Overmedicalisation Altering the meaning or understanding of experiences, so that
human problems are re-interpreted as medical problems requiring
medical treatment, without net beneﬁt to patients or citizens.
Professional associations promoting early management of acute low
back pain, despite its positive natural history. A recent randomised
trial found four sessions of physiotherapy provided within 2 weeks
of pain onset provides little beneﬁt to people with acute low back
pain.8
Associations promoting pain as the ‘ﬁfth vital sign.’ Mandating a
target of a pain score of 0 vastly expands the number of people who
require medical treatment, without any evidence that pursuing this
target reduces mobidity or mortality.
CT= computed tomography, MRI =magnetic resonance imaging.
Box 1. The Australian Physiotherapy Association’s list of
recommendations on tests treatments and procedures that
clinicians and patients should question.
 Don’t request imaging for patients with non-specific low
back pain and no indicators of a serious cause for low
back pain.
 Don’t request imaging of the cervical spine in trauma
patients, unless indicated by a validated decision rule.
 Don’t request imaging for acute ankle trauma, unless
indicated by the Ottawa Ankle Rules (localised bone
tenderness or inability to weight-bear, as defined in the
Rules).
 Don’t routinely use incentive spirometry after upper
abdominal and cardiac surgery.
 Avoid using electrotherapy modalities in the management
of patients with low back pain.
 Don’t provide ongoing manual therapy for patients with
adhesive capsulitis of the shoulder.
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There is also a clear need to review the curricula of
physiotherapy training programs. Evidence-based practice teach-
ing should include concepts of low-value healthcare, the possibili-
ty of overdiagnosis and overtreatment, and strategies to help
prevent these from occurring. Emotional distress appears to be an
important driver of health services overuse;17 physiotherapy
trainees should therefore be taught the importance of reducing
distress through effective reassurance. Brief and structured patient
education, for example, has high-quality evidence for its reassuring
effects in patients with back pain and is a promising alternative to
unnecessary diagnostic tests.23 Unfortunately, physiotherapists
tend to be less reassuring than physicians23 – a disadvantage that
might be improved by additional training in skills such as effective
patient education.
Professional organisations need to become more aware of
the dangers of unwittingly encouraging low-value care. For
example, given the favourable natural history of acute low back
pain, campaigns like ‘GetPT1st’, which promote seeing a
physiotherapist within 14 days of pain onset, could increase
the proportion of physiotherapy that is provided unnecessarily.
One might argue that a session or two of advice and reassurance
is unlikely to be harmful, and can have value outside of
improving upon natural history, such as reducing fears and
concerns.23 However, marketing by these organisations would
be more valuable if targeted towards conditions that usually do
not resolve spontaneously and where physiotherapy care is well
supported by evidence (eg, exercise for urinary incontinence,
knee osteoarthritis, falls and chronic obstructive pulmonary
disease).24
Another new step towards improving the value of physiother-
apy care is the formation of research programs such as ‘Wiser
Healthcare’. This research initiative will investigate causes of and
solutions to low-value healthcare, with a particular focus on
overdiagnosis and related overtreatment. Using examples across
musculoskeletal problems, cardiovascular disease and cancer, and
with strong input from physiotherapists, this 5-year collaboration
has the potential to discover new ways to improve the value of
healthcare.
Conclusion
Eliminating low-value services from physiotherapy care
altogether will be difﬁcult. Some clinicians and patients will ﬁnd
it hard to break old habits and new low-value habits will likely
emerge. Otherswill ﬁnd it hard to accept that some treatments and
tests are simply not beneﬁcial. On their own, ‘do not do’ lists are
unlikely to change practice. Instead, clinicians need practical tools
to help them discuss sensitive issues, such as overdiagnosis and
unnecessary tests and treatments, with their patients. An
increased understanding of these concepts among clinicians,
policymakers, and healthcare consumers will be a good start. If
we are to ultimately improve the value of physiotherapy care, the
logical next step is to translate an improved understanding of low-
value healthcare into wiser choices in practice.
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Paper of the Year 2016
The Editorial Board is pleased to announce the 2016 Paper of the Year Award. The winning paper is judged by a panel of members of the
International Advisory Board who do not have a conﬂict of interest with any of the papers under consideration. They vote for the paper
published in the 2016 calendar year that, in their opinion, has the best combination of scientiﬁc merit and application to the clinical
practice of physiotherapy.
The winning paper is ‘Video and computer-based interactive exercises are safe and improve task-speciﬁc balance in geriatric and
neurological rehabilitation: a randomised trial’.1 The authors are Maayken van den Berg from Flinders University and her colleagues from
Adelaide, Sydney and the Sunshine Coast.
People with mobility problems due to age or neurological conditions beneﬁt from inpatient exercise rehabilitation,2–5 especially with
higher doses of exercise.6–8 However, engaging older people in exercise rehabilitation is a challenge andmany inpatients receiving geriatric
and neurological rehabilitation are inactive for large portions of their day.9,10 The winning study by van den Berg et al1 examined whether
interactive computer or video games that are driven by the player’s gross physical movements (known as ‘exergames’) can improve the
effects of geriatric and neurological rehabilitation. This randomised trial identiﬁed that individually prescribed exergame-based exercises
were a safe and feasible way to increase the amount of repetitive task practice for inpatients in geriatric and neurological rehabiliation.
Furthermore, the intervention group ended the trial with signiﬁcantly better balance than the control group. The exergames were rated
favourably for usability and enjoyment by most participants in the experimental group.
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